Skip to main content

Inzirqo Dosage

Generic name: HYDROCHLOROTHIAZIDE 10mg in 1mL
Dosage form: powder, for oral suspension
Drug class: Thiazide diuretics

Medically reviewed by Drugs.com. Last updated on Jan 30, 2025.

Recommended Dosage for the Treatment of Hypertension

The recommended initial dose in adults is 25 mg orally daily given as a single dose. As needed, increase the dose to 50 mg orally daily, given as a single or two divided doses.


Pediatric Patients:

The recommended dose in pediatric patients is 1 to 2 mg/kg per day in one or two divided doses not to exceed 37.5 mg in patients less than 2 years of age and 100 mg in patients 2 to less than 13 years of age. In pediatric patients less than 6 months of age, doses up to 3 mg/kg per day in two divided doses may be required.

Recommended Dosage for the Treatment of Edema

The recommended adult dosage is 25 mg to 100 mg orally daily as a single or divided dose. Consider intermittent therapy to reduce the risk of electrolyte imbalances, i.e., administration on alternate days or on 3 to 5 days each week.


Pediatric Patients:

The recommended dose in pediatric patients is 1 to 2 mg/kg per day in one or two divided doses not to exceed 37.5 mg in patients less than 2 years of age and 100 mg in patients 2 to less than 13 years of age. In pediatric patients less than 6 months of age, doses up to 3 mg/kg per day in two divided doses may be required.

Preparation of Oral Suspension

INZIRQO is supplied as a powder for oral suspension and must be reconstituted prior to dispensing.

  • Gently shake the bottle to loosen the powder, add 66 mL of water and shake vigorously for minimum of 30 seconds. When reconstituted as directed, the solution will result in a 10 mg/mL concentration of hydrochlorothiazide.
  • Store the reconstituted solution at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Do not freeze.
  • Write the date of expiration of the reconstituted oral suspension (calculated as 30 days after reconstitution) on the bottle label.

Important Administration Instructions

  • Instruct patients or caregivers to use an oral dosing syringe to correctly measure the prescribed amount of medication. Inform patients that a bottle adapter and oral dosing syringes may be obtained from their pharmacy.
  • Advise patients to always shake the bottle well prior to each use.
  • INZIRQO may be administered with or without food.

Frequently asked questions

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.